On December 11, the Shanghai Stock Exchange Science and Technology Innovation Board Listing Committee held the 117th and 118th Listing Committee review meetings in 2020. At this meeting, the Science and Technology Innovation Board listing application of Xi’an Kangtuo Medical Technology Co., Ltd. (hereinafter referred to as “Kangtuo Medical”) was approved.

Kangtuo Medical is a high-tech enterprise focusing on the research and development, production and sales of Class III implantable medical devices. The company’s main products are used in the fields of neurosurgery skull repair and fixation and cardiothoracic surgery sternum fixation. At present, Kangtuo Medical has obtained 12 Class III implantable medical device registration certificates, involving pioneering products in multiple sub-sectors, and occupies a large domestic market share in the PEEK material skull repair and fixation product market. It is one of the few domestic companies that can provide diversified solutions for neurosurgery skull repair and fixation based on patient needs.

This time, Kangtuo Medical plans to raise approximately 523 million yuan, of which 100 million yuan will be used to supplement working capital and 423 million yuan will be used for the “Class III Implantable Medical Device Product Industry and R&D Base Project.”